NCT04063930View on ClinicalTrials.gov

The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions
Type 2 Diabetes Mellitus With Kidney Complications
Interventions
DRUG

LOKELMA 5 GM Powder for Oral Suspension

Sodium zirconium cyclosilicate (a hyperkalemia treatment)

DRUG

Placebos

Matching placebo

Trial Locations (1)

2820

RECRUITING

Steno Diabetes Center Copenhagen, Gentofte Municipality

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Zealand University Hospital

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER